miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy

Cardiovascular Therapeutics

Volumn 33, Issue 3, 2015, Pages 89-97

  Raut, Satish K ^a   Kumar, Akhilesh ^a   Singh, Gurinder B ^a   Nahar, Uma ^a   Sharma, Vibhuti ^a   Mittal, Anupam ^a   Sharma, Rajni ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cardiac hypertrophy; Cdc42; Diabetic cardiomyopathy; MiR 30c; Pak1

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLUCOSE; MICRORNA; MICRORNA 30C; MYOSIN HEAVY CHAIN BETA; P21 ACTIVATED KINASE 1; PROTEIN CDC42; STREPTOZOCIN; UNCLASSIFIED DRUG; CARDIAC MYOSIN; MIRN30 MICRORNA, HUMAN; MYH7 PROTEIN, HUMAN; MYOSIN HEAVY CHAIN; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CDC42 GENE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE INTAKE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; LIPID DIET; MALE; MOLECULAR BIOLOGY; NONHUMAN; PAK1 GENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CARDIOMEGALY; CELL LINE; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; UPREGULATION; WISTAR RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIAC MYOSINS; CARDIOMEGALY; CDC42 GTP-BINDING PROTEIN; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; MICRORNAS; MYOCYTES, CARDIAC; MYOSIN HEAVY CHAINS; P21-ACTIVATED KINASES; RATS; RATS, WISTAR; STREPTOZOCIN; UP-REGULATION;

EID: 84929191834     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/1755-5922.12113     Document Type: Article

References (32)

1. Jenkins MJ, Pearson JT, Schwenke DO, et al. Myosin heads are displaced from actin filaments in the in situ beating rat heart in early diabetes. Biophys J 2013;104:1065-1072.
2. Miki T, Yuda S, Kouzu H, Miura T. Diabetic cardiomyopathy: pathophysiology and clinical features. Heart Fail Rev 2013;18:149-166.
3. Pang Y, Hunton DL, Bounelis P, Marchase RB. Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes. Diabetes 2002;51:3461-3467.
4. Charron F, Tsimiklis G, Arcand M, et al. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev 2001;15:2702-2719.
5. Chiang YT, Jin T. P21-activated protein kinases and their emerging roles in glucose homeostasis. Am J Physiol Endocrinol Metab 2013;306:E707-E722.
6. Chong C, Tan L, Lim L, Manser E. The mechanism of PAK activation autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem 2001;276:17347-17353.
7. Mao K. P21-activated kinase 1 regulates pathological and physiological cardiac hypertrophy. University of South Dakota 2009.
8. Ye H, Ling S, Castillo AC, et al. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension 2013;61:1008-1013.
9. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007;13:613-618.
10. Clerk A, Pham FH, Fuller SJ, et al. Regulation of mitogen-activated protein kinases in cardiac myocytes through the small G protein Rac1. Mol Cell Biol 2001;21:1173-1184.
11. Ai X, Jiang A, Ke Y, Solaro RJ, Pogwizd SM. Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43. Cardiovasc Res 2011;92:106-114.
12. Maillet M, Lynch JM, Sanna B, York AJ, Zheng Y, Molkentin JD. Cdc42 is an antihypertrophic molecular switch in the mouse heart. J Clin Invest 2009;119:3079-3088.
13. Zhang M, Lv X-Y, Li J, Xu Z-G, Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2009;2008:704045.
14. Zhang C, Zhang L, Chen S, et al. The prevention of diabetic cardiomyopathy by non-mitogenic acidic fibroblast growth factor is probably mediated by the suppression of oxidative stress and damage. PLoS ONE 2013;8:e82287.
15. Feng B, Chen S, George B, Feng Q, Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 2010;26:40-49.
16. Zhang J, Chang J-J, Xu F, et al. MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot. Can J Cardiol 2013;29:1695-1703.
17. Cho WC, Wang E, Marincola FM, et al. TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness. Mol Cancer 2014;13:51.
18. Hadi HA, Al Suwaidi J. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 2007;3:853-876.
19. Watanabe K, Thandavarayan RA, Harima M, et al. Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy. Curr Cardiol Rev 2010;6:280-290.
20. Nagai T, Tanaka-Ishikawa M, Aikawa R, et al. Cdc42 plays a critical role in assembly of sarcomere units in series of cardiac myocytes. Biochem Biophys Res Commun 2003;305:806-810.
21. Manser E, Leung T, Salihuddin H, Zhao Z, Lim L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 1994;367:40-46.
22. Taglieri DM, Monasky MM, Knezevic I, et al. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A. J Mol Cell Cardiol 2011;51:988-996.
23. Clerk A, Sugden PH. Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 2000;86:1019-1023.
24. Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J, Kumar R. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J Biol Chem 1998;273:28238-28246.
25. Cheng Y, Ji R, Yue J, Yang J, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 2007;170:1831-1840.
26. Mao K, Kobayashi S, Jaffer ZM, et al. Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes. J Mol Cell Cardiol 2008;44:429-434.
27. Cheng G, Kasiganesan H, Baicu CF, Wallenborn JG, Kuppuswamy D, Cooper G. Cytoskeletal role in protection of the failing heart by β-adrenergic blockade. Am J Physiol-Heart Circ Physiol 2012;302:H675-H687.
28. Liu W, Zi M, Naumann R, et al. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation 2011;124:2702-2715.
29. Ke Y, Lei M, Solaro RJ. Regulation of cardiac excitation and contraction by p21 activated kinase-1. Prog Biophys Mol Biol 2008;98:238-250.
30. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, et al. miR-133 and miR-30 regulate connective tissue growth factor Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009;104:170-178.
31. Pan W, Zhong Y, Cheng C, et al. MiR-30-regulated autophagy mediates angiotensin II-induced myocardial hypertrophy. PLoS ONE 2013;8:e53950.
32. Jentzsch C, Leierseder S, Loyer X, et al. A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. J Mol Cell Cardiol 2012;52:13-20.